ANNEX 3. BLOOD TRANSFUSION SAFETYInformation for National <strong>Blood</strong> ProgrammesWHO strategy forblood safetyThe HIV/AIDS pandemic hasfocused particular attention onthe importance of preventingtransfusion-transmitted infection.WHO estimates that between 5% and10% of HIV infections worldwide aretransmitted through the transfusionof infected blood and blood products,while many thousands morerecipients of blood products areinfected <strong>with</strong> hepatitis B and Cviruses, syphilis and other infectiousagents, such as Chagas disease andmalaria.In the past, strategies to promoteblood safety tended to focus primarilyon screening donated blood fortransfusion-transmissible infections(TTIs). However, while systematicscreening is essential, it isinsufficient in itself to ensure thesafety of the blood supply.Evidence from all regions of the worldindicates that the absence of anationally-coordinated bloodprogramme, lack of safe blood donorsand the unnecessary clinical use oftransfusion are equally importantcontributory factors to thetransmission of infection bytransfusion.The WHO strategy for blood safetyemphasizes an <strong>int</strong>egrated four-foldapproach. Effective quality assuranceshould form an essential part of thisapproach.1. The establishment of acoordinated blood transfusionservice that can provide adequateand timely supplies of safe bloodfor all patients in need.2. The collection of blood only fromvoluntary non-remunerated blooddonors from low-risk populationsand the use of stringent donorselection procedures.3. The screening of all donated bloodfor transfusion-transmissibleinfections, including HIV, hepatitisviruses, syphilis and otherinfectious agents, and bloodgrouping, compatibility testingand processing of blood.4. A reduction in unnecessarytransfusions through theappropriate clinical use of blood,including the use of <strong>int</strong>ravenousreplacement fluids and othersimple alternatives to transfusion,wherever possible.<strong>Blood</strong> transfusion serviceA coordinated blood transfusionservice (BTS) is a prerequisite for anadequate supply of safe blood. Thenational health authority maydelegate responsibility for the bloodsupply to a non-profit nongovernmentalorganization, but theBTS should be developed <strong>with</strong>in theframework of the country’s healthcare infrastructure.The BTS should be established inaccordance <strong>with</strong> an agreed nationalblood policy and plan and <strong>with</strong>in alegislative framework. It should beresponsible for establishing andma<strong>int</strong>aining a national quality system,including the development ofguidelines and standard operatingprocedures, staff training, aninformation management system anda system for monitoring andevaluation.The BTS requires formal governmentcommitment, support and recognitionas a separate, identifiable programme<strong>with</strong> a budgeting and finance systemthat can ensure a sustainable bloodprogramme through cost recoveryand/or annual budget allocation. TheBTS should be managed by anExecutive Committee and assisted,where necessary, by specialistadvisory groups. BTS personnelshould include a medical director, aquality manager and staff <strong>who</strong> havebeen adequately trained in all aspectsof management, quality systems,blood donor recruitment, bloodcollection, screening, processing andthe storage and distribution of bloodand blood products.Low-risk blood donorsThe safer the source of donated blood,the safer the final product is likely tobe.122 ▲ WORLD HEALTH DAY ▼ SAFE BLOOD STARTS WITH ME
Voluntary non-remunerated blooddonors from low-risk populations <strong>who</strong>give blood regularly are thefoundation of a safe and adequatesupply of blood.In all regions of the world, a higherincidence and prevalence oftransfusion-transmissible infectionsare reported among family/replacement donors and, inparticular, paid donors. Furthermore,the use of family/replacement donorsmay constitute a hidden system ofpaid donation. These donors may notreliably respond to questionsregarding risk behaviour and theirsuitability as blood donors.A system of voluntary, regular nonremunerateddonation is thereforenot only safer than the use of family/replacement donors or paid donors. Italso enables more cost-effective useto be made of limited resources byreducing the volume of donated bloodthat has to be discarded because ofevidence of infectious diseasemarkers.<strong>World</strong>wide, more than 75 millionunits of blood are collected annually.In developed countries, the bloodsupply comes from voluntary nonremuneratedblood donors. Globally,developing countries contribute only16% of the voluntary nonremuneratedblood donors whichshows that the blood supply dependson a very high proportion of family/replacement/paid donors in thesecountries. High priority shouldtherefore be given to eliminating theuse of paid blood donors, convertingreplacement donors to voluntary nonremunerateddonors and motivatingthem to donate regularly.Many countries have <strong>int</strong>roducedlegislation requiring blood donationonly by voluntary non-remunerateddonors. In practice, this can only beachieved through the establishment ofan effective programme of blooddonor recruitment and retention,staffed by trained personnel, <strong>with</strong> anefficient donor information, educationand motivation programme.It also requires strict criteria fordonor selection and screening toidentify donors for deferral orexclusion, and efficient blood donorrecord systems. The identification ofdonor populations at low risk fortransfusion-transmissible infectionsand the monitoring of transfusiontransmissibleinfections in both thegeneral population and the donorpopulation are also key elements of astrategy for blood safety.The screening andprocessing of bloodWHO recommends that, beforetransfusion, all donated blood shouldbe tested for:• HIV• Hepatitis B• SyphilisWHO also recommends that, wherepossible and appropriate, donatedblood should be tested for otherinfectious agents, including hepatitisC, Chagas disease and malaria.Nevertheless, each year, more than13 million units of donated blood arenot tested for all transfusiontransmissibleinfections. Testing isalso sometimes unreliable,particularly when performed byinadequately trained staff or whenthere are shortages of suitableequipment or erratic supplies of testkits.Each country should thereforedevelop a national policy and strategyto ensure the systematic and effectivescreening of blood for transfusiontransmissibleinfections. Thisrequires:— the development of protocols forthe testing, selection andevaluation of the most appropriateand effective screening assays tobe used at each site— the development of qualitysystems for screening, bloodgrouping, compatibility testingand component preparation— the training, updating andcontinuing education of laboratorytechnical staff in BTSs andhospital blood banks— the central procurement, storageand distribution of reagents andmaterials to ensure continuity inscreening at all sites— an adequate budget.All donated blood units should also beroutinely tested for ABO and Rh (D)blood grouping and red cell antibodyscreening.Good laboratory practice usingstandard operating procedures andthe ma<strong>int</strong>enance of an effective bloodcold chain for the storage andtransportation of blood and bloodproducts is equally important.Reducing unnecessarytransfusionsThe primary responsibility forensuring the appropriate clinical useof blood lies <strong>with</strong> clinicians. However,the BTS has a key role in promoting123 ▲ WORLD HEALTH DAY ▼ SAFE BLOOD STARTS WITH ME
- Page 3 and 4:
WHO/BCT/01.03 • Original: English
- Page 5 and 6:
SAFE BLOOD STARTS WITH ME - BLOOD S
- Page 8 and 9:
It is our hope that the ideas and e
- Page 10 and 11:
continual technical assistance toen
- Page 13 and 14:
leaflets, flags, pins, stickers and
- Page 15 and 16:
WHO House in New Delhi. In thisregi
- Page 18 and 19:
SAFE BLOOD STARTS WITH ME - BLOOD S
- Page 20 and 21:
Another example of industrialpartne
- Page 22 and 23:
the University of Bujumburatwirled,
- Page 24 and 25:
Faithful Blood Donor Prizes1st 150k
- Page 26 and 27:
The Johannesburg cycling team.Polic
- Page 28 and 29:
SAFE BLOOD STARTS WITH ME - BLOOD S
- Page 31 and 32:
Masiyarwa Secondary School bannerpr
- Page 33 and 34:
Healy, American Association ofBlood
- Page 35 and 36:
What is blood used for?Red cells ar
- Page 37 and 38:
Youth solidarity with the blood don
- Page 39 and 40:
MaterialsEvery form imaginable was
- Page 41 and 42:
targeted at health personnel of the
- Page 43 and 44:
Metropolitan North HealthService: t
- Page 45 and 46:
SAFE BLOOD STARTS WITH ME - BLOOD S
- Page 47 and 48:
Campaign at local universityBlood d
- Page 49 and 50:
— Love of our fellow humanbeings;
- Page 51 and 52:
Laboratory in Coahuilatragedy, or p
- Page 53 and 54:
SAFE BLOOD STARTS WITH ME - BLOOD S
- Page 55 and 56:
During the event, diplomas andT-shi
- Page 57 and 58:
own video film on blood safety,usin
- Page 59 and 60:
pressure. The Bahrain DiabetesSocie
- Page 61 and 62:
SAFE BLOOD STARTS WITH ME - BLOOD S
- Page 63 and 64:
Quality management— quality depar
- Page 65 and 66:
donation campaigns. The specificobj
- Page 67 and 68:
SAFE BLOOD STARTS WITH ME - BLOOD S
- Page 69 and 70:
emunerated donors and toincrease th
- Page 71 and 72:
BLOOD SAVES LIVES IN WHO’S REGION
- Page 73 and 74:
SAFE BLOOD STARTS WITH ME - BLOOD S
- Page 75 and 76:
World Health Day 2000In promoting b
- Page 77 and 78:
and the mobile-team sessionrecorded
- Page 79 and 80: antigen. Six post-transfusion HIVin
- Page 81 and 82: collection on 5 April on thepremise
- Page 83 and 84: clinical use of blood products.Spec
- Page 85 and 86: ConclusionThe national authorities
- Page 87 and 88: Given the relatively short storagel
- Page 89 and 90: … a staggering two-thirdsof the S
- Page 91 and 92: Press conferenceA press conference
- Page 93 and 94: with messages on the theme of theda
- Page 95 and 96: SAFE BLOOD STARTS WITH ME - BLOOD S
- Page 97 and 98: SAFE BLOOD STARTS WITH ME - BLOOD S
- Page 99 and 100: ungalow. Six blood bankscollected 9
- Page 101 and 102: SAFE BLOOD STARTS WITH ME - BLOOD S
- Page 103 and 104: SAFE BLOOD STARTS WITH ME - BLOOD S
- Page 105 and 106: express gratitude to theorganizers
- Page 107 and 108: “we owe it to ourselves tohave he
- Page 109 and 110: (which in reality includes aproport
- Page 111 and 112: throughout the campaign, eitheras g
- Page 113 and 114: SAFE BLOOD STARTS WITH ME - BLOOD S
- Page 115 and 116: SAFE BLOOD STARTS WITH ME - BLOOD S
- Page 117 and 118: An altruistic IssueIt is not only i
- Page 119 and 120: Mongolian language anddistributed,
- Page 121 and 122: SAFE BLOOD STARTS WITH ME - BLOOD S
- Page 123 and 124: of effective blood screeningmeasure
- Page 125 and 126: ANNEX 1Pledge 25—A blood donor cl
- Page 127 and 128: — Albumin, which is an importantp
- Page 129: Are there any risksin giving blood?
- Page 133 and 134: ANNEX 4. THE APPROPRIATE CLINICAL U
- Page 135 and 136: Other than in the most exceptionall
- Page 137 and 138: should define the measures that wil
- Page 140: Department of Blood Safety and Clin